$FXE
Invesco CurrencyShares Euro Trust

2024 Q1 Form 10-K Financial Statement

#000095017024019061 Filed on February 23, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $1.424M $5.304M
YoY Change 56.35%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $207.9K $1.035M
YoY Change -26.98% -51.1%
Operating Profit
YoY Change
Interest Expense $0.00 $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings $1.216M $4.269M
YoY Change 94.27% -339.05%
Net Earnings / Revenue 85.39% 80.49%
Basic Earnings Per Share $0.58 $1.65
Diluted Earnings Per Share $0.58 $1.65
COMMON SHARES
Basic Shares Outstanding 2.050M 2.583M
Diluted Shares Outstanding 2.080M 2.583M

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $199.3M $214.0M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $200.1M $219.8M
YoY Change -27.5% -23.08%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $452.8K $226.0K
YoY Change -95.53% 90.41%
SHAREHOLDERS EQUITY
Retained Earnings $0.00 $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $200.1M $219.8M
YoY Change -27.5% -23.08%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income $1.216M $4.269M
YoY Change 94.27% -339.05%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $1.024M $3.741M
YoY Change 152.87% -283.07%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $1.219M $3.825M
YoY Change 207.58% 6598.48%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -10.85M -83.61M
YoY Change -47.59% -204.21%
NET CHANGE
Cash From Operating Activities 1.024M 3.741M
Cash From Investing Activities
Cash From Financing Activities -10.85M -83.61M
Net Change In Cash -14.74M -71.53M
YoY Change -1.13% -196.78%
FREE CASH FLOW
Cash From Operating Activities $1.024M $3.741M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Entity Registrant Name
EntityRegistrantName
Invesco CurrencyShares Euro Trust
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001328598
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Other Liability Current Related And Nonrelated Party Status Extensible Enumeration
OtherLiabilityCurrentRelatedAndNonrelatedPartyStatusExtensibleEnumeration
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
001-32694
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-3613421
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2023 dei City Area Code
CityAreaCode
800
CY2023 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2023 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2023 dei Trading Symbol
TradingSymbol
FXE
CY2023 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
252025000
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2050000
CY2023 dei Auditor Firm
AuditorFirmId
238
CY2023 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2023 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2023Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
214030570
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
285555944
CY2023Q4 fxe Subscriptions Receivable
SubscriptionsReceivable
5095966
CY2023Q4 us-gaap Due From Banks
DueFromBanks
154445
CY2023Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
505646
CY2022Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
169200
CY2023Q4 us-gaap Assets
Assets
219786627
CY2022Q4 us-gaap Assets
Assets
285725144
CY2023Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
152031
CY2022Q4 us-gaap Noninterest Bearing Deposit Liabilities
NoninterestBearingDepositLiabilities
7419
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73957
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
111264
CY2023Q4 us-gaap Liabilities
Liabilities
225988
CY2022Q4 us-gaap Liabilities
Liabilities
118683
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2150000
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2150000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2900000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2900000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
219560639
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
285606461
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
219786627
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
285725144
CY2023 us-gaap Investment Income Interest
InvestmentIncomeInterest
5303725
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
330793
CY2023 us-gaap Revenues
Revenues
5303725
CY2022 us-gaap Revenues
Revenues
330793
CY2023 us-gaap Sponsor Fees
SponsorFees
1034961
CY2022 us-gaap Sponsor Fees
SponsorFees
1108325
CY2023 us-gaap Interest Expense
InterestExpense
0
CY2022 us-gaap Interest Expense
InterestExpense
1008181
CY2023 us-gaap Operating Expenses
OperatingExpenses
1034961
CY2022 us-gaap Operating Expenses
OperatingExpenses
2116506
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4268764
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.65
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.65
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.62
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.62
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2582603
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2582603
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2884521
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2884521
CY2023 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
3825434
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4268764
CY2023 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
-443330
CY2022 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
57109
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2022 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
1842822
CY2023 us-gaap Net Income Loss
NetIncomeLoss
4268764
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1785713
CY2023 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
336446
CY2022 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
169200
CY2023 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-37307
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
35918
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-124198
CY2023 fxe Increase Decrease In Cash Due From Depository
IncreaseDecreaseInCashDueFromDepository
154445
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3740566
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2043193
CY2023 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
3825434
CY2022 us-gaap Payments Of Capital Distribution
PaymentsOfCapitalDistribution
57109
CY2023 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
149222668
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
703013411
CY2023 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
229147352
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
622725114
CY2023 fxe Increase Decrease In Payable For Euro Dollar Deposits Overdrawn
IncreaseDecreaseInPayableForEuroDollarDepositsOverdrawn
144612
CY2022 fxe Increase Decrease In Payable For Euro Dollar Deposits Overdrawn
IncreaseDecreaseInPayableForEuroDollarDepositsOverdrawn
7419
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-83605506
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
80238607
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8339566
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-4282894
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-71525374
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
73912520
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285555944
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
211643424
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
214030570
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285555944
CY2022 us-gaap Interest Paid Net
InterestPaidNet
1132379
CY2023 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-12-05
CY2023Q4 fxe Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
CY2023 fxe Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2023 fxe Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<div style="display:flex;margin-top:12pt;justify-content:flex-start;align-items:baseline;margin-bottom:0;min-width:4.537%;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:4.537%;display:inline-flex;justify-content:flex-start;">B.</span><div style="width:100%;display:inline;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Accounting Estimates</span></div></div><p style="text-indent:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span></p>
CY2023 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.48
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.02
CY2023 us-gaap Payments Of Dividends
PaymentsOfDividends
3825434
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
57109
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023 fxe Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2023Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0270
CY2023 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
143007863
CY2023 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
212205189
CY2023Q4 us-gaap Cash
Cash
198364675
CY2023Q4 us-gaap Cash
Cash
219125708
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
679568682
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
596144853
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
1970473
CY2022Q4 us-gaap Cash
Cash
267562001
CY2022Q4 us-gaap Cash
Cash
285555944
CY2023 fxe Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 fxe Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2023Q4 fxe Non Rule10 B51 Arr Modified Flag
NonRule10B51ArrModifiedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-019061-index-headers.html Edgar Link pending
0000950170-24-019061-index.html Edgar Link pending
0000950170-24-019061.txt Edgar Link pending
0000950170-24-019061-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxe-20231231.htm Edgar Link pending
fxe-20231231.xsd Edgar Link pending
fxe-ex23_1.htm Edgar Link pending
fxe-ex31_1.htm Edgar Link pending
fxe-ex31_2.htm Edgar Link pending
fxe-ex32_1.htm Edgar Link pending
fxe-ex32_2.htm Edgar Link pending
fxe-ex97_1.htm Edgar Link pending
img173717624_0.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fxe-20231231_htm.xml Edgar Link completed
img173717624_1.jpg Edgar Link pending
img173717624_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending